Expanded Carrier Screening in Gamete Donation
Author Information
Author(s): Nicky Hudson, Cathy Herbrand, Lorraine Culley
Primary Institution: Centre for Reproduction Research, De Montfort University
Hypothesis
How is expanded carrier screening being used to avoid genetic risk in IVF treatment using donor gametes?
Conclusion
Expanded carrier screening is reshaping the IVF landscape by allowing for more sophisticated donor selection to prevent genetic disorders in offspring.
Supporting Evidence
- ECS allows testing for hundreds of genetic conditions simultaneously, unlike traditional methods.
- Clinics are increasingly using ECS to market donors as offering risk-free conception.
- ECS has the potential to shift the logic of gamete donation from overcoming infertility to ensuring healthy offspring.
- Donors may feel increased responsibility for the health of offspring due to ECS.
Takeaway
This study looks at a new test that helps choose egg and sperm donors to make sure babies are healthy and don't have genetic diseases.
Methodology
The study synthesizes data from two large-scale studies on gamete donation and expanded carrier screening.
Potential Biases
Potential bias in donor selection and the commercialization of genetic screening may influence clinical practices.
Limitations
The study does not address the full range of genetic conditions that may not be tested for, and the implications of ECS on donor health and decision-making are not fully explored.
Participant Demographics
The study involves gamete donors and recipients, with a focus on clinics in Europe and the United States.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website